Reply to thread

https://seekingalpha.com/article/4764210-biogen-inc-biib-ceo-chris-viehbacher-presents-at-td-cowen-45th-annual-health-care-conference


especially this part:  "We're going to be playing cat and mouse over the next three years with a declining MS franchise and then the new products. So I would say over the next two to three years, if you actually look at the annual results, it's going to be flattish to low growth." -CV